Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns.
Iron is released in a desferrioxamine (DFO)-chelatable form (DCI) when erythrocytes are challenged by an oxidative stress. In beta-thalassemic erythrocytes, both DCI content and release (after aerobic incubation for 24h) are increased and correlated with the fetal hemoglobin (HbF) levels. Since erythrocytes from newborns have an extremely high content of HbF and are exposed to conditions of oxidative stress, the release of iron in these erythrocytes was investigated. The erythrocyte DCI content was increased in preterm but not in term newborns as compared to adults, while the release was increased in both preterm and term erythrocytes. The level of plasma non protein-bound iron (NPBI), which was not detectable in adults, was much higher in preterm than in term newborns. When term plus preterm newborns were divided in two groups, normoxic and hypoxic, according to cord blood pH, it was found that both iron release and NBPI were markedly higher in the hypoxic newborns compared to normoxic ones. Similar results were also obtained when the preterm and term infants were considered separately on the basis of cord blood pH. Therefore, iron release and NPBI are higher when conditions of hypoxia occur. In fact, when the values for iron release and NPBI were separately plotted against cord blood pH values, significant negative correlations were seen in both cases. NPBI was correlated with iron release seen in all the newborns and a significant part of the released iron could be recovered into the incubation medium at the end of the incubation.
Ciccoli
Lucia
L
Department of Pathophysiology and Experimental Medicine, University of Siena, Siena, Italy.
Rossi
Viviana
V
Leoncini
Silvia
S
Signorini
Cinzia
C
Paffetti
Patrizia
P
Bracci
Rodolfo
R
Buonocore
Giuseppe
G
Comporti
Mario
M
D000328:Adult; D001798:Blood Proteins / Q000378:metabolism; D016022:Case-Control Studies; D002614:Chelating Agents; D003676:Deferoxamine; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D005312:Fetal Blood / Q000378:metabolism*; D006801:Humans; D000860:Hypoxia / Q000097:blood*; D007231:Infant, Newborn; D007234:Infant, Premature; D007501:Iron / Q000097:blood*; D008297:Male; D008706:Methemoglobin / Q000378:metabolism; D018384:Oxidative Stress; D011485:Protein Binding
D001798:Blood Proteins; D002614:Chelating Agents; D008706:Methemoglobin; D007501:Iron; D003676:Deferoxamine